morpholinoanthracycline mx2 has been researched along with Nervous System Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furuta, T; Matsumoto, K; Mizumatsu, S; Ohmoto, T; Ono, Y; Tamiya, T | 1 |
1 other study(ies) available for morpholinoanthracycline mx2 and Nervous System Diseases
| Article | Year |
|---|---|
Intrathecal chemotherapy with MX2 for treating glioma dissemination in vivo.
Topics: Animals; Antineoplastic Agents; Brain; Brain Neoplasms; Carubicin; Dose-Response Relationship, Drug; Feasibility Studies; Glioma; Injections, Intraventricular; Injections, Spinal; Male; Nervous System Diseases; Rats; Rats, Wistar; Survival Analysis | 2000 |